The alteration of branched-chain amino acid metabolism in diabetes has been linked to the ability of glucose and insulin to modulate LAT1 expression levels in the pancreas, explaining several symptoms of the disease, such as sarcopenia and damages to the retina [43,44]. Here, SLC7A5 is linked to diabetes mellitus.